$469.97
0.650.14%
At close: -
$467.98
-1.99-0.42%
After Hours: 7:37 PM EDT
Comments
Loading...
Vertex Pharmaceuticals (NASDAQ:VRTX) Stock, Earnings Estimates, EPS, And Revenue
Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 5
EPS Estimate
$4.380
Quarterly Revenue Estimate
$2.80B
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$10.63B
Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Vertex Pharmaceuticals (VRTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-10 | $3.98 | $4.02 | -1.00 % |
| Q3 | 2024-11-04 | $4.38 | $4.14 | 5.80 % |
| Q2 | 2024-08-01 | $-12.83 | $4.14 | -409.9 % |
| Q1 | 2024-05-06 | $4.76 | $4.02 | 18.4 % |
Vertex Pharmaceuticals (VRTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-10 | $2.91B | $2.78B | 4.75 % |
| Q3 | 2024-11-04 | $2.77B | $2.72B | 1.91 % |
| Q2 | 2024-08-01 | $2.65B | $2.66B | -0.53 % |
| Q1 | 2024-05-06 | $2.69B | $2.57B | 4.67 % |
FAQ
When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?
Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 10, 2025 for Q4.
What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?
The Actual EPS was $3.98, which missed the estimate of $4.02.
What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?
The Actual Revenue was $2.9B, which beat the estimate of $2.8B.
Browse earnings estimates, EPS, and revenue on all stocks.